(Q54578085)
Statements
Endocrine effects of the tyrosine kinase inhibitor vandetanib in patients treated for thyroid cancer. (English)
Sylvie Brailly-Tabard
1 reference
Isabelle Borget
Sylvie Salenave
Philippe Chanson
Maryse Brassard
Barbara Neraud
Séverine Trabado
Eric Baudin
Sophie Leboulleux
Martin Schlumberger
Jacques Young
29 June 2011
96
9
2741-2749